Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-19-006512
Filing Date
2019-11-14
Accepted
2019-11-14 13:37:01
Documents
7
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K thct_10k.htm 10-K 660936
2 CERTIFICATION thct_ex311.htm EX-31.1 7441
3 CERTIFICATION thct_ex312.htm EX-31.2 7532
4 CERTIFICATION thct_ex321.htm EX-32.1 2554
5 CERTIFICATION thct_ex322.htm EX-32.2 2571
6 thct_10kimg2.jpg GRAPHIC 16430
7 thct_10kimg3.jpg GRAPHIC 35120
  Complete submission text file 0001477932-19-006512.txt   753534
Mailing Address 645 FRONT ST., #2202 SAN DIEGO CA 92101
Business Address 645 FRONT ST., #2202 SAN DIEGO CA 92101 702-602-8422
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

EIN.: 260164981 | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-55994 | Film No.: 191218637
SIC: 3523 Farm Machinery & Equipment